These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31115496)
41. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents. Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188 [TBL] [Abstract][Full Text] [Related]
42. Curcumin induces apoptosis in human gastric carcinoma AGS cells and colon carcinoma HT-29 cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cao A; Li Q; Yin P; Dong Y; Shi H; Wang L; Ji G; Xie J; Wu D Apoptosis; 2013 Nov; 18(11):1391-1402. PubMed ID: 23881281 [TBL] [Abstract][Full Text] [Related]
43. The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity. Lu Y; Ma J; Song Z; Ye Y; Fu PP; Lin G Arch Toxicol; 2018 Nov; 92(11):3403-3414. PubMed ID: 30244272 [TBL] [Abstract][Full Text] [Related]
44. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas. Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951 [TBL] [Abstract][Full Text] [Related]
45. FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria. Doghman-Bouguerra M; Granatiero V; Sbiera S; Sbiera I; Lacas-Gervais S; Brau F; Fassnacht M; Rizzuto R; Lalli E EMBO Rep; 2016 Sep; 17(9):1264-80. PubMed ID: 27402544 [TBL] [Abstract][Full Text] [Related]
46. Coumestrol induces mitochondrial dysfunction by stimulating ROS production and calcium ion influx into mitochondria in human placental choriocarcinoma cells. Lim W; Yang C; Jeong M; Bazer FW; Song G Mol Hum Reprod; 2017 Nov; 23(11):786-802. PubMed ID: 29040664 [TBL] [Abstract][Full Text] [Related]
47. Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro. Yu K; Wang T; Li Y; Wang C; Wang X; Zhang M; Xie Y; Li S; An Z; Ye T Biomed Pharmacother; 2017 Aug; 92():403-411. PubMed ID: 28575805 [TBL] [Abstract][Full Text] [Related]
48. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Starenki D; Hong SK; Lloyd RV; Park JI Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367 [TBL] [Abstract][Full Text] [Related]
49. The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways. Ruggiero C; Doghman-Bouguerra M; Ronco C; Benhida R; Rocchi S; Lalli E Mol Cell Endocrinol; 2018 Oct; 474():57-64. PubMed ID: 29474877 [TBL] [Abstract][Full Text] [Related]
50. Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR. Gonçalves AP; Videira A; Soares P; Máximo V Life Sci; 2011 Sep; 89(11-12):371-7. PubMed ID: 21807000 [TBL] [Abstract][Full Text] [Related]
51. Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines. Hoffmann S; Maschuw K; Hassan I; Reckzeh B; Wunderlich A; Lingelbach S; Zielke A Thyroid; 2005 Sep; 15(9):1011-20. PubMed ID: 16187909 [TBL] [Abstract][Full Text] [Related]
52. Potentiation of mitotane action by rosuvastatin: New insights for adrenocortical carcinoma management. Boulate G; Amazit L; Naman A; Seck A; Paci A; Lombes A; Pussard E; Baudin E; Lombes M; Hescot S Int J Oncol; 2019 Jun; 54(6):2149-2156. PubMed ID: 30942448 [TBL] [Abstract][Full Text] [Related]
53. Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane. Sbiera S; Kendl S; Weigand I; Sbiera I; Fassnacht M; Kroiss M Mol Cell Endocrinol; 2019 Jan; 480():36-41. PubMed ID: 30315857 [TBL] [Abstract][Full Text] [Related]
54. MCM5 as a target of BET inhibitors in thyroid cancer cells. Mio C; Lavarone E; Conzatti K; Baldan F; Toffoletto B; Puppin C; Filetti S; Durante C; Russo D; Orlacchio A; Di Cristofano A; Di Loreto C; Damante G Endocr Relat Cancer; 2016 Apr; 23(4):335-47. PubMed ID: 26911376 [TBL] [Abstract][Full Text] [Related]
55. Mitotane exhibits dual effects on steroidogenic enzymes gene transcription under basal and cAMP-stimulating microenvironments in NCI-H295 cells. Lin CW; Chang YH; Pu HF Toxicology; 2012 Aug; 298(1-3):14-23. PubMed ID: 22546480 [TBL] [Abstract][Full Text] [Related]
56. Small interfering RNA (siRNA) against Slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin. Pan Y; Liu P; Chen D; Dou L Cancer Biomark; 2017; 18(4):357-366. PubMed ID: 28128736 [TBL] [Abstract][Full Text] [Related]
58. Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells Jo S; Ha TK; Han SH; Kim ME; Jung I; Lee HW; Bae SK; Lee JS Anticancer Res; 2017 Apr; 37(4):1705-1710. PubMed ID: 28373432 [TBL] [Abstract][Full Text] [Related]
59. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381 [TBL] [Abstract][Full Text] [Related]
60. Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro. Ferrari SM; Fallahi P; La Motta C; Bocci G; Corrado A; Materazzi G; Galleri D; Piaggi S; Danesi R; Da Settimo F; Miccoli P; Antonelli A Surgery; 2014 Nov; 156(5):1167-76. PubMed ID: 25151558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]